/>>4. 17 Volumetric flask (10 mL) . >4. 18 Aflatoxin immunomagnetic beads pretreatment kit: recovery rate ≥85%
Main technology and structural performance of electric heating stirring tank
Time of Update: 2022-06-13
5. Tank body: The inner surface is mirror polished, and the roughness Ra≤0.
"Dual-channel" special drug retail performance revealed
Time of Update: 2022-06-09
On April 30, 2021, the National Medical Insurance Administration released the "Reference List of Partially Negotiated Drug Equipping Institutions for New Access in 2020 (First Batch)", which
Picking the Pearl of "High-Performance Fiber" Shenzhen Gene's Domestic "High-Electrical Strength Insulating Aramid Paper" Appears
Time of Update: 2022-06-06
On September 25, a "high electrical strength insulating aramid paper" was unveiled at the new product launch conference in Dingnan County, Ganzhou City, Jiangxi Province .
The performance of 29 pharmaceutical companies has been exposed. What is the impact of centralized procurement, national talks, epidemic situation, and cost?
Time of Update: 2022-06-03
41%; in the first quarter of 2022, Shutaishen achieved revenue of 123 million yuan, a year-on-year increase of 6.
Thermal coal futures performed well in September, the market handed in a perfect answer
Time of Update: 2022-06-03
On September 29, the Q5500 thermal coal price of Qinhuangdao Port, Ordos, was 610 yuan, hitting a new high for more than 14 months, and it has reached the red alert zone.
Co-infection with HBV, can HIV blockade be performed?
Time of Update: 2022-06-02
signing the informed consent form: PEP medication regimen: Bikempinol tablets, 1 tablet/day, for 28 days; follow-up requirements: 2 weeks, 4 weeks, 8 weeks, and 24 weeks after taking the medicine, follow-up visits, and at the same time closely monitor
How to improve the performance of pharmaceutical purified water equipment to meet pharmaceutical water quality standards?
Time of Update: 2022-05-30
Not only that, the system design, material selection, preparation process, storage, distribution and use of the pharmaceutical purified water equipment should meet the requirements of the pharmaceutical production quality management regulations.
Sanofi's 2022Q1 performance: China increased by 13.4%!
Time of Update: 2022-05-30
/>328 billion euros (+17%) . > > In terms of geographical distribution of revenue, Russia provided Sanofi with the strongest growth driver (+34. 4%), followed
Cape Testing Performance in 2021: Net profit declines by 13.5%, main business revenue is stable
Time of Update: 2022-05-26
During the reporting period, the company's testing services realized business income of 141,082,010.
Nearly 40 pharmaceutical companies disclosed their performance in the first quarter of 2022, with a high pre-happy rate
Time of Update: 2022-05-22
91% year-on-year According to the first quarter performance forecast released by Mingde Bio, the net profit attributable to shareholders of listed companies in the first quarter of 2022 is expected to be 1.
The annual sales exceeded one million units, and the actual performance of Yuyue Medical continued the legend of oxygen production
Time of Update: 2022-05-20
As evidenced by the performance, relevant data from the China Medical Device Industry Association shows that the sales volume of Yuyue oxygen concentrators exceeded 1 million units last year, and the global market share exceeded 50.
The pharmaceutical industry performed well in the first quarter, with the added value increasing by 11.8% year-on-year
Time of Update: 2022-05-19
Among them, Tonghua Dongbao expects to achieve a net profit of 817 million yuan attributable to shareholders of listed companies in the first quarter, a year-on-year increase of 142.
AACR 2022: Olaparib in combination with cyclophosphamide and metformin performs well in endometrial cancer (ENDOLA trial)
Time of Update: 2022-05-18
metforminENDOLA is a phase 1/2 open-label, dose-escalation trial evaluating olaparib in combination with cyclophosphamide and metformin metronomic therapy in elderly patients with multiple prior therapy for recurrent advanced endometrial cancer .
The high-performance organic pigment project of Liaoning Longyu New Materials Co., Ltd. was officially put into production
Time of Update: 2022-05-17
The production scale of high-performance organic pigments reaches 100,000 tons per year, and the annual output value is expected to reach 5 billion yuan .
The performance of Japanese tire companies' non-tire business has grown significantly
Time of Update: 2022-05-15
Among them, all of Bridgestone's businesses including diversification/chemical products have achieved profitability, the sports business launched by Sumitomo Rubber has achieved results, and the non-tire business income of Yokohama Rubber and Toyo Tire has increased significantly year-on-year.
The overall performance of the traditional Chinese medicine sector achieved high growth and ushered in greater investment opportunities
Time of Update: 2022-05-14
Among them, the overall performance of the traditional Chinese medicine sector has also achieved high growth, with 30 traditional Chinese medicine companies having a net profit of more than 100 million yuan .
Fujian Changsu High-performance Membrane Project started construction
Time of Update: 2022-05-13
It is understood that the Fujian Changsu high-performance membrane project is built adjacent to the nylon production base that Zhonglun New Materials has put into production .
